Search for: "TEVA PHARMACEUTICAL INDUSTRIES LIMITED"
Results 41 - 60
of 136
Sorted by Relevance
|
Sort by Date
30 Oct 2006, 5:58 am
District Court for the District of Columbia in Teva Pharmaceuticals v. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ),… [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
30 Jan 2020, 10:49 am
Purdue Pharma and Teva Pharmaceuticals – Oklahoma – $355 million. [read post]
18 Aug 2010, 12:19 am
Apotex Pty Ltd; CSL Limited v. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]
11 May 2011, 4:54 am
General UNCTAD: Bundle of opportunities to improve medicines access in LDCs (IP Watch) Australia: Why IP professionals must take ‘gene patent’ opponents seriously (Patentology) Australia: FCA finds fatal flaw in Plant Breeders Rights Act: Elders Rural Services Australia Limited v Registrar of Plant Breeder’s Rights (Patentology) (ipwars) Finland: Decision on parallel import of pharmaceuticals (Class 46) Italy: Again on MA filing as a preparatory act of marketing… [read post]
29 Jun 2013, 8:43 am
In 2008 the Commission conducted an investigation into the pharmaceutical industry with particular reference as to how the industry (allegedly) used its patent in order to restrict competition. [read post]
17 Nov 2010, 1:48 am
(Patently-O) US: Amicus brief filed by Alnylam Pharmaceuticals argues that Funk Bros. is about obviousness, not patent eligibility: AMP v USPTO (Holman’s Biotech IP Blog) US: Amicus briefs in AMP v USPTO: Genetic Alliance (Patent Docs) US: Patent expirations will stabilise the pharmaceutical industry (BiotechBlog) US: Generic industry headed for a ‘180-day exclusivity cliff’ (FDA Law Blog) US: PTO clarifies PTE availability in post-PhotoCure and… [read post]
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
18 Feb 2013, 12:46 am
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Circadin (Melatonin) - UK: EWHC upholds refusal of SPC: Neurim Pharmaceuticals (1991) Limited v. [read post]
30 Apr 2019, 7:22 am
As the legislation is written it covers every type of industry whereas in reality different issues arise. [read post]
30 Sep 2010, 11:44 am
Teva, Cisco, and the Generic Pharma Association: The current standard creates an incentive for patent applicants to conceal material information from the USPTO. [read post]
11 Nov 2013, 5:48 am
Sharon Hausdorff (Deputy General Patent Counsel, Teva Pharmaceutical Industries Ltd) then addressed "Due diligence". [read post]
31 Dec 2011, 1:00 pm
C-4329; and Teva Pharmaceuticals, Inc. and Cephalon, Dkt. [read post]
2 Dec 2006, 1:45 pm
In Brussels, they join a notable list of other corporate and government leaders from around the world, including Bertrand Gellie, Director of Pharmaceutical Directorate for the European Patent Office; Georgina Evans, Head of Trade Marks for Shell International Limited; Yehudah Livneh, General Patent Counsel for Teva Pharmaceutical Industries; and Hideo Ozawa, Chief Patent Expert, General Manager Patent Division, Law & Intellectual Property Unit for… [read post]
29 Nov 2010, 7:24 am
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for Thirty-Six ProfessorsPetitioner's reply The following two cases were consolidated by the Court: Title:… [read post]
